Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 219 pembrolizumab 198 Magnetic Resonance Spectroscopy 197 Carboplatin 174 Cisplatin 140 Biopsy 133 Nivolumab 131 Paclitaxel 115 Radiotherapy 111 Cyclophosphamide 111 Gemcitabine 104 durvalumab 90 Dexamethasone 90 atezolizumab 77 Radiation 72 Rituximab 71 Lenalidomide 69 Pemetrexed 66 Bevacizumab 66 Doxorubicin 65 Docetaxel 63 Ipilimumab 59 Etoposide 57 olaparib 54 Fluorouracil 52 venetoclax 50 Taxes 50 Oxaliplatin 50 Radiosurgery 49 Prednisone 49

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × EC regimen × 90 days × Clear all

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡